{"entity":{"type":"insider","cik":"0001365343","url":"/insider/0001365343","json_url":"/insider/0001365343.json","name":"Nader Francois","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":7,"first":"2010-04-02","last":"2022-09-13","span_basis":"filed_date"},"name_variants":[{"name":"Nader Francois","source":"filing","n_filings":7,"first_seen":"2010-04-02","last_seen":"2022-09-13"}],"transactions":[{"id":9205276,"accession":"0000899243-22-030924","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-030924","line_url":"/filing/0000899243-22-030924#line-3","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36500.0,"shares_display":"36,500","price_per_share":3.72,"price_display":"3.72","price_state":"stated","total_value":135780.0,"total_display":"135,780.00","total_whole":"135,780","shares_owned_after":138500.0,"shares_owned_after_display":"138,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-09-13","scope":"insider"},{"id":6533036,"accession":"0000899243-22-026684","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-026684","line_url":"/filing/0000899243-22-026684#line-5","is_derivative":false,"issuer_cik":"0001365343","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001365343","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36500.0,"shares_display":"36,500","price_per_share":3.72,"price_display":"3.72","price_state":"stated","total_value":135780.0,"total_display":"135,780.00","total_whole":"135,780","shares_owned_after":138500.0,"shares_owned_after_display":"138,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-25","scope":"insider"},{"id":9205278,"accession":"0000899243-22-030924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030924","line_url":"/filing/0000899243-22-030924#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52000.0,"shares_display":"52,000","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":188240.0,"total_display":"188,240.00","total_whole":"188,240","shares_owned_after":102000.0,"shares_owned_after_display":"102,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-09-13","scope":"insider"},{"id":6533025,"accession":"0000899243-22-026684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-026684","line_url":"/filing/0000899243-22-026684#line-2","is_derivative":false,"issuer_cik":"0001365343","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001365343","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52000.0,"shares_display":"52,000","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":188240.0,"total_display":"188,240.00","total_whole":"188,240","shares_owned_after":102000.0,"shares_owned_after_display":"102,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-25","scope":"insider"},{"id":9205277,"accession":"0000899243-22-030924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-030924","line_url":"/filing/0000899243-22-030924#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":176000.0,"total_display":"176,000.00","total_whole":"176,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-09-13","scope":"insider"},{"id":6533020,"accession":"0000899243-22-026684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-026684","line_url":"/filing/0000899243-22-026684#line-1","is_derivative":false,"issuer_cik":"0001365343","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001365343","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":176000.0,"total_display":"176,000.00","total_whole":"176,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-25","scope":"insider"},{"id":6638141,"accession":"0001127602-22-014263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-014263","line_url":"/filing/0001127602-22-014263#line-2","is_derivative":false,"issuer_cik":"0001365343","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001365343","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3196.0,"shares_display":"3,196","price_per_share":136.1,"price_display":"136.10","price_state":"stated","total_value":434975.6,"total_display":"434,975.60","total_whole":"434,976","shares_owned_after":20607.0,"shares_owned_after_display":"20,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider"},{"id":4325126,"accession":"0000890465-13-000025","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000890465-13-000025","line_url":"/filing/0000890465-13-000025#line-8","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43458.0,"shares_display":"43,458","price_per_share":32.3558,"price_display":"32.36","price_state":"stated","total_value":1406118.3564,"total_display":"1,406,118.36","total_whole":"1,406,118","shares_owned_after":87820.0,"shares_owned_after_display":"87,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-27","filed_date":"2013-09-30","scope":"insider"},{"id":4325114,"accession":"0000890465-13-000025","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000890465-13-000025","line_url":"/filing/0000890465-13-000025","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":33.092956066666666,"price_display":"33.09","price_state":"stated","total_value":4963943.41,"total_display":"4,963,943.41","total_whole":"4,963,943","shares_owned_after":94317.0,"shares_owned_after_display":"94,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-26","filed_date":"2013-09-30","scope":"insider","n_lines":2},{"id":5427757,"accession":"0001474064-13-000064","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001474064-13-000064","line_url":"/filing/0001474064-13-000064#line-18","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148367.0,"shares_display":"148,367","price_per_share":11.6773,"price_display":"11.68","price_state":"stated","total_value":1732525.9691,"total_display":"1,732,525.97","total_whole":"1,732,526","shares_owned_after":217478.0,"shares_owned_after_display":"217,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-10","filed_date":"2013-04-10","scope":"insider"},{"id":5427745,"accession":"0001474064-13-000064","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001474064-13-000064","line_url":"/filing/0001474064-13-000064#line-14","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":11.2656,"price_display":"11.27","price_state":"stated","total_value":1689840.0,"total_display":"1,689,840.00","total_whole":"1,689,840","shares_owned_after":236860.0,"shares_owned_after_display":"236,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-09","filed_date":"2013-04-10","scope":"insider"},{"id":5427728,"accession":"0001474064-13-000064","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001474064-13-000064","line_url":"/filing/0001474064-13-000064#line-9","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":11.0053,"price_display":"11.01","price_state":"stated","total_value":1650795.0,"total_display":"1,650,795.00","total_whole":"1,650,795","shares_owned_after":236860.0,"shares_owned_after_display":"236,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-08","filed_date":"2013-04-10","scope":"insider"},{"id":8933578,"accession":"0001474064-11-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001474064-11-000059","line_url":"/filing/0001474064-11-000059#line-1","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":160800.0,"total_display":"160,800.00","total_whole":"160,800","shares_owned_after":132690.0,"shares_owned_after_display":"132,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-09","filed_date":"2011-11-10","scope":"insider"},{"id":7497241,"accession":"0001474064-10-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001474064-10-000018","line_url":"/filing/0001474064-10-000018#line-1","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001365343","owner_name":"Nader Francois","owner_display_name":"Nader Francois","owner_url":"/insider/0001365343","role":"Director, Officer (President, CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19350.0,"shares_display":"19,350","price_per_share":3.37,"price_display":"3.37","price_state":"stated","total_value":65209.5,"total_display":"65,209.50","total_whole":"65,210","shares_owned_after":149658.0,"shares_owned_after_display":"149,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-03","filed_date":"2010-04-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001827506","name":"Talaris Therapeutics, Inc.","url":"/issuer/0001827506","role":"Director","n_filings":2,"first_seen":"2022-07-25","last_seen":"2022-09-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001682852","name":"Moderna, Inc.","url":"/issuer/0001682852","role":"Director","n_filings":1,"first_seen":"2022-05-12","last_seen":"2022-05-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000890465","name":"NPS PHARMACEUTICALS INC","url":"/issuer/0000890465","role":"Director, Officer (President, CEO and Director)","n_filings":4,"first_seen":"2010-04-02","last_seen":"2013-09-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001365343","retrieved_at":"2026-08-23T01:18:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}